Showing results (151-160 of 271) with videos related to
Sort By:
Pageof 28
Vascular Pharmacology|May 16, 2019
Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in miceLynn Roth, Carole Van der Donckt, Besa Emini Veseli, et al.Journal of Alzheimer'S Disease : JAD|October 8, 2016
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without DepressionDoortje W Dekens, Petrus J W Naudé, Sebastiaan Engelborghs, et al.Neuroimage. Clinical|February 5, 2021
Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysisTania M Setiadi, Sander Martens, Esther M Opmeer, et al.Neurobiology of Aging|June 4, 2018
Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosisFederica Perrone, Rita Cacace, Sara Van Mossevelde, et al.Frontiers in Psychiatry|May 16, 2022
A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease StudiesTanja J de Rijke, M H Edwina Doting, Saskia van Hemert, et al.Journal of Neurochemistry|June 11, 2013
Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosisMyrthe Rouwette, Jean-Paul Noben, Jack Van Horssen, et al.Vascular Pharmacology|December 28, 2018
Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosisAmmar Kurdi, Lynn Roth, Bieke Van der Veken, et al.Plos One|March 5, 2021
Amyloid burden quantification depends on PET and MR image processing methodologyGuilherme D Kolinger, David Vállez García, Antoon T M Willemsen, et al.Journal of Mental Health Research in Intellectual Disabilities|October 7, 2022
Dementia in People with Severe/Profound Intellectual (and Multiple) Disabilities: Practice-Based Observations of SymptomsMaureen B G Wissing, Andrea S Fokkens, Roos Dijkstra, et al.Cell Cycle (Georgetown, Tex.)|March 20, 2015
The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndromeSien Braat, Charlotte D'Hulst, Inge Heulens, et al.Pageof 28